Page 163 - Programme book for The International Liver Congress 2015, EASL ILC 2015

P0245 THE IL-6/SIL6R AND STAT3 AXIS IS CRUCIAL FOR ePOSTERS
HEPATOPROTECTION AND SUPPRESSION OF LIVER
P0246 CANCER IN FEMALE MICE WITH CHRONIC LIVER INJURY
P0247 Jonathan H. Axelrod, Tali Lanton, Anat Shriki, Amir Sonnenblick,
P0248 Rinat Abramovitch, Orit Pappo, Amnon Peled, Stefan Rose-John,
P0250 Eithan Galun*, Israel
P0251
P0252 POTENT AKT/PKB INHIBITOR REDUCES AKT
PHOSPHORYLATION AND TUMOR CELL GROWTH IN VITRO
AND INVIVO
Kristina Mäemets-Allas*, Janeli Viil, Viljar Jaks, Estonia

C1GALT1 IS OVEREXPRESSED IN CHOLANGIOCARCINOMA
AND C1GALT1 KNOCKDOWN INHIBITS MALIGNANT
BEHAVIORS OF CHOLANGIOCARCINOMA CELLS
Min-Chuan Huang*, Miao-Juei Huang,Yao-Ming Wu, Taiwan

H-1PARVOVIRUS: A NEW THERAPEUTIC STRATEGY
TARGETING HEPATOCELLULAR CARCINOMA
Olivier Morales*, Emmanuel Boleslawski, Dhafer Mrizak,
Madjda Fenghour, Jean Rommelaere,Yvan deLaunoit, Nadira Delhem,
France

EFFECT OF IRREVERSIBLE ELECTROPORATION
(IRE) ON THE PORCINE LIVER: COMPARISON WITH
RADIOFREQUENCY ABLATION
Yoshiyuki Kobayashi, Fuminori Moriyasu*, Katsutoshi Sugimoto,
Mayumi Ando, Takatomo Sano, Ikuo Nakamura, Hisashi Oshiro, Japan

HBX SENSITIZE HEPATOCELLULARCARCINOMA CELLS TO
LAPATINIB BY UP-REGULATING ERBB3
Jhen-Yu Chen*, Taiwan

IDENTIFICATION OF THE APICAL SODIUM BILE SALT
TRANSPORTER (ASBT) AS A NOVEL MOLECULAR
TARGET TO ENHANCE THE SENSITIVITY OF
CHOLANGIOCARCINOMA TO CHEMOTHERAPY
Elisa Lozano, Rocio I. Macias, Maria J. Monte, Oscar Briz,
Felipe Jimenez, Silvia Jimenez, Beatriz Castaño, Ruba Al-Abdulla,
Faten Al-Aqil, Angel Hernandez, Jesus M. Banales, Maria A. Serrano,
Jose J. Marin*, Spain

Vienna, Austria • April 22–26, 2015 163